(Q40107921)

17 September 2017

Brain tumor formation in tuberous sclerosis depends on Erk activation (English)

1 reference

17 September 2017

1 reference

1 reference

4

Sergiusz Jozwiak

1 reference

Pawel Krzysztof Wlodarski

17 September 2017

9

object named as

Pawel Wlodarski

1 reference

17 September 2017

Marcin Roszkowski

7

0 references

Wiesława Grajkowska

object named as

Wieslawa Grajkowska

2

0 references

Katarzyna Kotulska

object named as

Katarzyna Kotulska

3

0 references

author name string

Jaroslaw Jozwiak

1

1 reference

17 September 2017

Wojciech Zalewski

5

1 reference

17 September 2017

Agnieszka Zajaczkowska

6

1 reference

17 September 2017

Artur Slupianek

8

1 reference

17 September 2017

1 January 2007

1 reference

17 September 2017

NeuroMolecular Medicine

1 reference

17 September 2017

9

1 reference

17 September 2017

117-127

1 reference

17 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02685886

17 September 2017

0 references

cites work

Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells

1 reference

https://api.crossref.org/works/10.1007%2FBF02685886

Differential localization of hamartin and tuberin and increased S6 phosphorylation in a tuber

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685886

Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685886

Mechanism of ribosomal p70S6 kinase activation by granulocyte macrophage colony-stimulating factor in neutrophils: cooperation of a MEK-related, THR421/SER424 kinase and a rapamycin-sensitive, m-TOR-related THR389 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685886

Human Colon Carcinoma Ki-ras2 Oncogene and Its Corresponding Proto-Oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685886

Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02685886

Akt regulates growth by directly phosphorylating Tsc2

21 January 2018

1 reference

12 December 2020

The NF1 tumor suppressor critically regulates TSC2 and mTOR.

1 reference

12 December 2020

Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth.

1 reference

12 December 2020

Rheb binds and regulates the mTOR kinase

1 reference

12 December 2020

Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase

1 reference

12 December 2020

Subependymal giant cell astrocytoma with positive tuberin expression--case report

1 reference

12 December 2020

Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors

1 reference

12 December 2020

AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression

1 reference

12 December 2020

Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin

1 reference

12 December 2020

Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions

1 reference

12 December 2020

Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis.

1 reference

12 December 2020

Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.

1 reference

12 December 2020

Alternate FGF2-ERK1/2 signaling pathways in retinal photoreceptor and glial cells in vitro

1 reference

12 December 2020

Giant cells: contradiction to two-hit model of tuber formation?

1 reference

12 December 2020

Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex

1 reference

12 December 2020

Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins

1 reference

12 December 2020

Neuropathology of tuberous sclerosis

1 reference

12 December 2020

Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients

1 reference

12 December 2020

Lessons from hereditary colorectal cancer

1 reference

12 December 2020

Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.

1 reference

12 December 2020

[Tests for loss of heterozygosity in tuberous sclerosis]

1 reference

12 December 2020

Tuberous sclerosis-associated neoplasms express activated p42/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumor growth

1 reference

12 December 2020

A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes

1 reference

12 December 2020

Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis

1 reference

12 December 2020

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

1 reference

12 December 2020

Phosphorylation and binding partner analysis of the TSC1-TSC2 complex

1 reference

12 December 2020

Tsc2 is not a critical target of Akt during normal Drosophila development

1 reference

12 December 2020

Hamartin and tuberin: working together for tumour suppression

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02685886

1 reference

17 September 2017

1 reference